LOADING
Comparing Eli Lilly and Company (LLY) and Thermo Fisher Scientific (TMO), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $173.4B |
| P/E Ratio | -- | 25.6 |
| Forward P/E | -- | 18.8 |
| PEG Ratio | -- | 1.73 |
| EPS | -- | $18.20 |
| Revenue Growth (YoY) | -- | 7.2% |
| Profit Margin | -- | 15.0% |
| Return on Equity | -- | 13.0% |
| Dividend Yield | -- | -- |
| Beta | -- | 0.97 |
| 52-Week High | -- | $643.35 |
| 52-Week Low | -- | $384.44 |
| Volume | -- | -- |